1. Home
  2. IOT vs VTRS Comparison

IOT vs VTRS Comparison

Compare IOT & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Samsara Inc.

IOT

Samsara Inc.

N/A

Current Price

$41.46

Market Cap

23.3B

Sector

Technology

ML Signal

N/A

Logo Viatris Inc.

VTRS

Viatris Inc.

N/A

Current Price

$17.67

Market Cap

18.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IOT
VTRS
Founded
2015
1961
Country
United States
United States
Employees
N/A
30000
Industry
Retail: Computer Software & Peripheral Equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.3B
18.7B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
IOT
VTRS
Price
$41.46
$17.67
Analyst Decision
Buy
Buy
Analyst Count
26
12
Target Price
★ $52.07
$19.70
AVG Volume (30 Days)
5.1M
★ 7.9M
Earning Date
09-03-2026
11-05-2026
Dividend Yield
N/A
★ 2.75%
EPS Growth
★ 92.86
N/A
EPS
★ 0.10
0.05
Revenue
$1,618,635,000.00
★ $14,299,900,000.00
Revenue This Year
$26.37
$3.42
Revenue Next Year
$20.02
$1.68
P/E Ratio
$412.20
★ $349.40
Revenue Growth
★ 29.57
N/A
52 Week Low
$23.38
$9.74
52 Week High
$47.47
$18.43

Technical Indicators

Market Signals
Indicator
IOT
VTRS
Relative Strength Index (RSI) 56.97 59.26
Support Level $36.52 $15.94
Resistance Level $42.34 $18.30
Average True Range (ATR) 1.57 0.51
MACD 0.24 -0.02
Stochastic Oscillator 65.69 54.87

Price Performance

Historical Comparison
IOT
VTRS

About IOT Samsara Inc.

Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers range from small and medium-sized businesses to state and local governments.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: